CBA Pharma's Unattributed - III Round

CBA Pharma raised a round of funding on January 30, 2015.

CBA Pharma is a specialty pharmaceutical company organized to exclusively manufacture, market, license and distribute to the medical oncology community a drug, CBT-1, developed to be an effective trea…

Articles about CBA Pharma's Unattributed - III Round: